# clm_063460475B4C

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: quarterly_net_income  
value: 7,396,000,000 United States dollar  
valid_from: 2026-03-31  
valid_to: 2026-06-30  
published: 2026-04-30  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_2FBA71C4F385  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company quarterly net income: 7,396,000,000 United States dollar", as of 2026-03-31 (until 2026-06-30). Claim clm_063460475B4C, https://asof.is/claim/clm_063460475B4C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947826000045/0000059478-26-000045-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q1 FY2026, filed 2026-04-30  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947826000045/0000059478-26-000045-index.htm (primary, SEC EDGAR 10-Q Q1 FY2026, published 2026-04-30)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_net_income | 5,582,500,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_063460475B4C](/claim/clm_063460475B4C.md) | [clm_74B5C29B477B](/claim/clm_74B5C29B477B.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.